De-SPAC Business Combination: LOI to Closing Mechanics

A de-SPAC transaction is the process by which a special purpose acquisition company completes the initial business combination it was formed to pursue. Unlike a conventional acquisition, the de-SPAC involves two sets of stockholders with different economic rights and interests (SPAC public stockholders with redemption rights and a trust-backed floor, and existing target company stockholders seeking liquidity or a public market for their shares), a parallel PIPE financing process, and an SEC disclosure and review process that approximates a second public offering for the combined entity. Managing these concurrent processes requires an understanding of the legal mechanics at each phase.

This sub-article is part of the SPAC and De-SPAC Transactions: Legal Guide. It covers the full de-SPAC business combination process in detail: target identification and exclusivity mechanics; the key terms of the letter of intent including valuation, PIPE contingency, minimum cash, and sponsor promote adjustments; definitive merger agreement structure and the choice between reverse triangular and direct merger forms; valuation methodologies used in de-SPAC transactions including discounted cash flow, trading multiples, and forward multiples; PIPE financing negotiation and disclosure; minimum cash condition mechanics; non-redemption agreements and redemption backstops; sponsor promote earn-back and forfeiture structures; interim covenants and material adverse change provisions; antitrust review under the Hart-Scott-Rodino Act and foreign investment review under CFIUS; regulatory approvals; shareholder and board approvals for both the SPAC and the target; closing conditions and the drop dead date; and extension mechanics and the redemption wave problem.

For an acquisition-related de-SPAC question, share the parties' roles, proposed structure, current documents and next decision when requesting an assessment. Acquisition Stars can assess the M&A workstream and coordinate separately scoped securities, tax or other specialist work where appropriate. Agree responsibility for each workstream before work begins.

Target Identification and Exclusivity

The target identification process begins after the SPAC's IPO closes and the sponsor's management team begins actively evaluating potential business combination candidates. SPAC sponsors typically identify a target sector focus in the IPO prospectus (for example, technology-enabled services, healthcare, or industrial manufacturing) that is broad enough to preserve flexibility but specific enough to establish credibility with investors who evaluate the sponsor's sector expertise.

Before target outreach, have securities counsel review permitted communications, confidentiality arrangements and applicable transaction-filing requirements. An NDA addresses confidentiality; it provides no blanket exemption from securities-law restrictions. Keep a record of the materials shared, recipients and approval process so later public disclosure can be checked against the actual negotiations.

Document the scope and duration of exclusivity in the signed LOI or separate agreement. Identify which party is restricted, prohibited activities, permitted responses to unsolicited approaches, extension mechanics and termination rights. A target should understand the consequences of taking itself out of the market while financing and diligence remain unresolved. The actual agreement determines whether exclusivity is mutual.

Translate the LOI valuation into a fully diluted capitalization and cash-at-closing model. Include debt, cash, transaction expenses, sponsor interests, warrants, incentive equity, PIPE terms and potential redemptions. A headline enterprise value alone leaves the target owners unable to assess their eventual ownership or the combined company's funding. A public stockholder's redemption decision remains separate from the negotiated target valuation.

Letter of Intent: Valuation, PIPE Contingency, and Promote Adjustments

The letter of intent in a de-SPAC transaction covers several categories of terms: economic terms including pre-money enterprise valuation and deal structure (merger vs. contribution); financing contingencies including the minimum PIPE commitment required before proceeding; protections for the SPAC and its stockholders including the minimum cash condition and representations about the target's business; and process terms including exclusivity, due diligence access rights, and the timeline to definitive documentation.

Pre-money enterprise valuation in a de-SPAC LOI is typically expressed as a multiple of the target's projected EBITDA or revenue for the forward year, and the LOI will specify whether the valuation is calculated on a cash-free, debt-free basis (with cash and debt adjusted at closing) or on a fully diluted basis including all options, warrants, and convertible instruments. The valuation methodology matters because the target's management may have strong views about which projections to use as the reference period (trailing twelve months vs. next twelve months vs. the next full fiscal year), and a difference in methodology can produce meaningfully different equity splits even when the nominal enterprise value is the same.

Identify whether the LOI makes financing a condition to further negotiation, signing or closing, and which provisions are binding. Compare that language with the eventual subscription and merger agreements. If funding or valuation assumptions change, determine the permitted response under the actual documents rather than assume an automatic right to renegotiate or terminate.

If sponsor compensation or an earn-back changes during negotiations, reconcile the LOI, sponsor agreement, capitalization model and public disclosure. Record the interests affected, conditions and intended implementation. The actual amendment determines the commitment; an informal commercial understanding leaves a gap in the document set.

Definitive Merger Agreement: Structure and Key Provisions

The definitive merger agreement in a de-SPAC transaction is the governing contract for the business combination and is typically executed simultaneously with the PIPE subscription agreements and the ancillary agreements (registration rights agreement, sponsor letter agreement amendment, employment agreements). The merger agreement is filed as an exhibit to the Form 8-K announcing the transaction and is publicly disclosed at the time of signing, triggering the proxy statement drafting and SEC review process.

In a reverse triangular merger, a merger subsidiary combines with the target and the target survives, subject to the actual structure and governing law. The continuing entity can matter for contracts and licenses, but consent and change-of-control provisions still require individual review. Do not infer that entity survival eliminates every assignment, control or regulatory approval requirement.

A direct merger (in which the target merges directly into the SPAC) is structurally simpler and avoids the step of forming a merger subsidiary but creates assignment risk for any target contract or license that prohibits assignment by operation of law. In a direct merger, the target ceases to exist and all of its assets and liabilities are assumed by the SPAC by operation of law. State licensing and regulatory authorizations, which are often non-transferable, may lapse or require reapplication in a direct merger, which is a significant risk for targets in regulated industries such as healthcare, financial services, or defense.

Negotiate representations, remedies and any survival or indemnification provisions using the actual consideration, parties and recourse structure. Identify whose information supports each statement, material qualifications and available recovery. Payment in shares alone establishes neither the importance of indemnification nor the extent of recourse against a particular seller.

Valuation Methodologies: DCF, Trading Multiples, and Forward Multiples

Management projections require careful disclosure review in a de-SPAC transaction. The SEC, June 29, 2024 explains the final rules adopted in January 2024, including disclosures about material assumptions when projections appear in de-SPAC filings. Have securities counsel assess the basis, presentation and applicable liability standards for the projections actually used in the transaction.

A valuation analysis may use discounted cash flow, comparable-company or transaction approaches. Identify the selected method, measurement periods, peer group and material assumptions, including revenue, margins, capital needs and discounting. Ask the financial adviser to explain the sensitivity of the conclusion. A model should expose rather than conceal differences between current results and forecast performance.

Comparable company trading multiples apply EV/EBITDA, EV/Revenue, or price-to-earnings ratios derived from the public trading prices of comparable companies to the target's projected financial metrics. The selection of comparable companies is a judgment-intensive process, and sponsors in de-SPAC transactions have sometimes selected peer groups that include the highest-valued companies in the target's sector rather than the most operationally similar ones, producing reference multiples that flatter the target's valuation. The SEC, June 29, 2024 describes the adopted projection disclosures and changes affecting the availability of the PSLRA safe harbor. Review the selected peer group and assumptions against the applicable final requirements.

If a valuation uses forecast earnings or revenue, compare the target and peer figures on a consistent time basis. Identify the forecast owner, assumptions and support, and show the effect of changing the projection. Have financial and securities advisers assess the disclosure and applicable liability framework before a forecast-based valuation is presented to investors.

PIPE Financing Negotiation and Disclosure

PIPE investors purchase securities through negotiated subscription agreements, with funding and conditions coordinated with the business combination. Identify the security, subscription price, investor commitments, funding conditions and termination rights in the actual agreements. Have securities counsel determine the required transaction disclosure and exhibit filings rather than assuming every PIPE uses the same terms or signing sequence.

Compare the PIPE's price and rights with the consideration and rights received by other holders. Discounts, preferences, warrants, price adjustments or other protections can change the financing's effective cost and dilution. The capitalization model should show those terms explicitly so the target board can evaluate cash raised alongside the ownership issued to obtain it.

Read the PIPE registration-rights agreement for its filing deadline, effectiveness obligations, permitted suspensions, damages and exceptions. These are contractual commitments with consequences for post-closing cash and legal work. Assign an owner to each deliverable and confirm that financial information, auditor support and filing resources are available. Use the negotiated documents to establish the calendar rather than a generic market range.

Minimum Cash Condition and Non-Redemption Agreements

Read the defined minimum-cash calculation, protected party, measurement time, available sources, deductions and waiver or termination rights in the actual agreement. A financing commitment can have its own conditions and may differ from cash counted for the contractual test. Reconcile the result to the funds flow before deciding the condition is satisfied.

Set the proposed cash condition against the finance team's operating plan, required debt payments, transaction expenses and any seller cash consideration. Identify the forecast period and assumptions expressly. Model redemption scenarios and funding contingencies so the board can evaluate what remains available for operations under each case.

Non-redemption agreements are entered into by the sponsor with institutional investors who hold Class A shares and agree not to exercise their redemption right at the business combination vote. In exchange, the investor typically receives a transfer of a specified number of founder shares from the sponsor. The economic value of the founder share transfer to the investor is the mechanism by which the sponsor purchases the investor's commitment to remain in the SPAC rather than redeeming, and the cost to the sponsor is the dilution of the sponsor's own economic interest in the combined company. Non-redemption agreements must be disclosed in the proxy statement because they represent a material transaction between the sponsor and a SPAC stockholder that is relevant to the stockholder's assessment of the proposed business combination.

Have disclosure counsel review non-redemption arrangements against the applicable filing requirements and the current transaction facts. The SEC's de-SPAC compliance guide identifies disclosure areas that include agreements concerning redemptions, financing transactions, conflicts and dilution. If an arrangement changes after filing, ask counsel whether the investor materials need an update before the next transaction step.

Reconcile the cash condition with the latest closing documents

A financing commitment appears in the forecast. Before counting it toward the merger agreement's cash condition, ask whether its conditions and timing permit that treatment under the actual agreement. Expected funding and cash available for the contractual test can be different amounts.

Have counsel read the defined cash test alongside the finance team's current redemption estimate, financing documents and transaction expenses. Check the measurement time and exclusions. Leave conditional or unsettled amounts visible instead of turning an assumption into confirmed proceeds.

If the calculation shows a shortfall, decide what the parties are proposing to change. Additional financing, a revised condition and a waiver raise different document questions. Ask counsel which consents are needed and whether investor materials require an update before the next step.

Alex Lubyansky's perspective on counsel's strategic role is relevant at this point: identify the negotiated term that needs a legal decision and bring counsel into that decision. Meeting the cash condition and funding the combined company's operating plan still need separate assessments.

The SEC's de-SPAC guide describes financing, redemption and dilution disclosures. It does not determine whether a particular contractual cash condition is met.

Submit Transaction Details with your role and the unresolved document question. Securities and disclosure work requires a transaction-specific scope.

Sponsor Promote Earn-Back Structures and Interim Covenants

A negotiated sponsor earn-back or forfeiture arrangement can make specified interests conditional on future events. Describe the actual interests at risk, performance condition, measurement period and treatment on a later sale. SEC de-SPAC compliance guidance addresses sponsor compensation, conflicts, dilution and related disclosure. Show how the arrangement changes the capitalization and sponsor incentives under the transaction's actual terms.

For any earn-back arrangement, identify who holds the shares while conditions remain open, whether voting and distribution rights continue, and how forfeiture or vesting is implemented. Test the agreement against stock splits, a change of control, delisting and a dispute about the trading-price calculation. Treat any illustrative price or percentage as a model assumption; obtain the operative thresholds from the signed documents.

Interim covenants in the de-SPAC merger agreement govern the conduct of both the SPAC and the target during the period between signing and closing. Target covenants typically require the target to operate in the ordinary course of business consistent with past practice and prohibit it from taking actions outside the ordinary course without SPAC consent (including making acquisitions, incurring material indebtedness, entering into material contracts, paying dividends or making distributions, or materially changing its compensation practices). SPAC covenants typically prohibit the SPAC from amending its charter, waiving trust account conditions, taking actions that would cause the trust to fall below the per-share minimum, or entering into any other acquisition agreements during the exclusivity period.

Material adverse change (MAC) provisions define the circumstances under which the SPAC can terminate the merger agreement based on a deterioration in the target's business between signing and closing. De-SPAC MAC definitions typically follow the convention established in conventional M&A transactions: they define a MAC as a material adverse effect on the business, financial condition, assets, or results of operations of the target, subject to carve-outs for effects arising from general economic conditions, industry-wide developments, changes in law or regulation, acts of God, and changes in the market price of the SPAC's shares (though market-price changes are not themselves a MAC, they may be a symptom of a MAC if caused by a target-specific development). The COVID-19 pandemic forced significant litigation over MAC definitions in 2020, and the resolution of that litigation has informed the drafting of carve-outs in subsequent de-SPAC agreements.

Antitrust Review (HSR) and Foreign Investment Review (CFIUS)

Have antitrust counsel assess HSR reportability using the actual parties, ultimate parent entities, interests acquired, valuation, exemptions and current thresholds. FTC current HSR thresholds lists a $133.9 million base size-of-transaction threshold for 2026. Crossing that figure alone resolves neither the full filing analysis nor the identity of the filing persons. Record the applicable conclusion before committing to a closing date.

Where HSR filing is required, coordinate the applicable waiting-period calculation and any agency requests with antitrust counsel. FTC premerger-notification resources provide current program guidance. The agreement should address required cooperation, additional information and any acceptable remedy commitment. Closing remains subject to the actual clearance requirements and other conditions, rather than an assumed early-termination outcome.

Assess foreign-investment issues using the actual investors, control and other rights, business activities and transaction steps. U.S. Treasury CFIUS resources describe the framework. Some transactions involve mandatory declarations while others may warrant a voluntary filing; involvement of a technology, infrastructure or data business alone supplies an incomplete answer. Have the specialist determine jurisdiction, any mandatory requirement and the appropriate closing condition.

Regulatory Approvals and the Proxy Statement Process

List any sector-specific licenses and approvals associated with the target's actual activities. Assign the relevant regulatory specialist to determine whether the structure triggers consent, notice, new applications or operating restrictions. Coordinate those dependencies with financing and the outside date; one completed regulatory workstream leaves other required permissions outstanding.

Securities counsel should identify the proxy, registration or tender-offer filings required for the actual transaction. SEC de-SPAC compliance guidance explains the rule framework, including target co-registration and treatment of covered shell-company combinations. The choice depends on the transaction and parties; paying cash alone supplies an incomplete basis for assuming registration can be omitted.

Build the staff-review workstream around the target's financial statements, business disclosures, projections, sponsor conflicts, financing and dilution. Assign factual and accounting owners before filing and maintain a log of open comments and required amendments. SEC de-SPAC compliance guidance describes the relevant disclosure rules. The number of comment rounds and review duration remain dependent on the filing and unresolved issues, so avoid a promised market timetable.

Shareholder and Board Approvals: SPAC and Target

Determine whether the proposed structure requires a stockholder meeting, another approval route or tender-offer procedures. For a meeting, verify the voting classes, quorum, approval threshold and any sponsor voting arrangements under applicable law, organizational documents and exchange requirements. SEC de-SPAC compliance guidance describes a minimum dissemination requirement generally based on the lesser of 20 calendar days or the jurisdiction's maximum permitted period; counsel should calculate the applicable calendar for the filing and vote.

Board-process obligations depend on applicable corporate law, the actual conflicts and transaction facts, alongside securities disclosure requirements. SEC de-SPAC compliance guidance addresses sponsor compensation, conflicts and dilution disclosure. Corporate counsel should separately advise on approvals and process, including any independent advice or committee work warranted by the circumstances. Redemption rights have conditions and economic consequences that must be disclosed accurately.

Have corporate counsel map board, stockholder and other approvals under each entity's governing law, charter and signed agreements. Identify the required sequence and permitted form of consent. Record any appraisal, notice, class-vote or contractual voting issue relevant to the structure instead of importing a generic majority threshold.

Closing Conditions, Drop Dead Date, and Extension Mechanics

Reconcile the actual closing conditions with the transaction structure: effectiveness of any registration statement, required votes, financing, minimum cash, regulatory requirements, representations, covenants and ancillary agreements. A standalone proxy statement has a different filing status from a registration statement. Keep each condition's completion evidence and any permitted waiver separate so approval of one milestone cannot be mistaken for satisfaction of all closing requirements.

The merger agreement's outside date and the SPAC charter's business-combination deadline are separate commitments. Review termination rights, breach qualifications, extension provisions and the steps required under the charter. If the charter deadline arrives first, determine whether an authorized extension is feasible and funded. The parties should assess the transaction's remaining financing and cash conditions before relying on that route.

Read the actual charter and related agreements for available extension procedures, required approvals, redemption opportunities and any funding obligation. Record the notice, meeting and deposit requirements that apply to that SPAC. An extension can change the cash model, so update available trust cash and transaction funding after the relevant redemption information is known.

Redemption Waves, Transaction Failure, and Restructuring Options

Redemptions reduce the trust cash available for the business combination and can affect whether the financing and minimum-cash conditions are met. Model the transaction using identified redemption scenarios without presenting those assumptions as observed market rates. For each scenario, show the resulting cash, debt, fees and ownership. Assign responsibility for any replacement financing and determine whether the parties have a right or obligation to proceed.

When redemptions are expected to be high, sponsors have several structural options to bridge the funding gap. First, the PIPE can be upsized to replace anticipated redemption proceeds, provided institutional investors are willing to commit additional capital at acceptable terms. Second, the target can agree to lower the minimum cash condition, accepting a smaller cash infusion at closing in exchange for a higher equity allocation or other concessions. Third, the sponsor can enter into non-redemption agreements as described above, effectively paying a portion of the promote to retain public stockholders. Fourth, the combined company can arrange post-closing debt financing (a bridge loan or revolving credit facility) to supplement the reduced trust proceeds, provided a lender is willing to commit to the combined company in advance of the closing.

When none of these options is sufficient to bridge the funding gap, the parties face a choice between terminating the merger agreement and negotiating a restructured transaction. A renegotiated transaction at a lower valuation may satisfy the minimum cash condition at the reduced trust balance but requires the target's board to accept terms that may be materially less favorable than the original agreement. Termination and restart with a fresh search is the least attractive option for the sponsor (because it consumes time within the charter deadline and creates reputational risk) but may be preferable to closing a transaction at terms that are not in the long-term interest of the combined company or its stockholders. The decision requires careful judgment and a clear-eyed assessment of the alternatives, informed by counsel who understands both the transaction dynamics and the SPAC's remaining runway.

Frequently Asked Questions